Providence Medical Technology, Inc. is a privately-held medical device company developing innovative solutions addressing the $1 billion worldwide cervical spine market. The company is focused on commercializing the DTRAX platform of single-use, tissue-sparing implants and instruments for cervical fusion, as well as other technologies that improve cervical spine procedures for both physicians and patients.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/27/15 | $12,000,000 | Venture |
Aphelion Capital Stanmore Medical Investments | undisclosed |
| 12/20/16 | $10,500,000 | Series E |
Aphelion Capital MVM Partners Stanmore Medical Investments | undisclosed |
